SCHEMBL295925

SCHEMBL295925

Brc1ccc(-c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.71
MAPK1 P28482 2/20 0.71
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TDP1 Q9NUW8 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ACHE P22303 2/20 0.43
NR1H4 Q96RI1 1/20 0.42
CYP1A1 P04798 2/20 0.42
CYP1B1 Q16678 2/20 0.42
CYP1A2 P05177 1/20 0.42
TNKS O95271 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL261051 0.98 MAPK1 (0.67) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL30114969 0.98 MAPK1 (0.67) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL21577244 0.95 ALDH1A1 (0.62) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL29696841 0.93 ALDH1A1 (0.57) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL1665653 0.93 ALDH1A1 (0.57) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL21624612 0.91 MAPK1 (0.64) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL13777185 0.91 MAPK1 (0.64) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL13777184 0.91 MAPK1 (0.64) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL19283290 0.90 MAPK1 (0.58) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL391049 0.90 MAPK1 (0.58) ALDH1A1MAPK1NPC1RAB9ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11171292-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-11-09 US disclosed
US-20200373488-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2020-11-26 US disclosed
US-20180083191-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2018-03-22 US disclosed
US-20180083191-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2018-03-22 US disclosed
US-9831440-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-11-28 US disclosed
US-9831440-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-11-28 US disclosed
US-9831440-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-11-28 US disclosed
US-20170018711-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2017-01-19 US disclosed
US-20170018711-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2017-01-19 US disclosed
US-20170018711-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2017-01-19 US disclosed
EP-1985613-A2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-10-29 EP disclosed
CN-101253150-A Anthracene derivatives SEMICONDUCTOR ENERGY LAB (JP) 2008-08-27 CN disclosed
EP-1928828-A1 ANTHRACENE DERIVATIVE Semiconductor Energy Laboratory Co., Ltd. (JP) 2008-06-11 EP disclosed
US-20080122344-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-29 US disclosed
US-20080122344-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-29 US disclosed
US-20070075632-A1 Anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-04-05 US disclosed
US-20070075632-A1 Anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-04-05 US disclosed
US-20070075632-A1 Anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-04-05 US disclosed
WO-2007029530-A1 ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-03-15 WO disclosed
WO-2007029530-A1 ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080122344-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE CYBA, CRY2, LAS1L ALDH1A1 70/4885MAPK1 981/4885NPC1 3091/4885
US-20070075632-A1 Anthracene derivative CRY2, XPOT, CRY1 ALDH1A1 61/4885MAPK1 3937/4885NPC1 2513/4885
US-20170018711-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED CYP1A1, CYP1A2, XPOT ALDH1A1 59/4885MAPK1 1272/4885NPC1 3427/4885
US-20200373488-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED CYP1A1, CYP1A2, XPOT ALDH1A1 59/4885MAPK1 1272/4885NPC1 3427/4885
US-11171292-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used CYP1A1, CYP1A2, XPOT ALDH1A1 59/4885MAPK1 1272/4885NPC1 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.